Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Oct-24 8:06 PM View:  | Liquidia Corp (LQDA) | 14-Oct-24 | Private Sale (Planned) | 8,053 | $11.11 | $89,450.30 | (< 1%) 2.41M to 2.4M | |
| 15-Jul-24 6:32 PM View: | Liquidia Corp (LQDA) | 12-Jul-24 | Private Sale (Planned) | 8,053 | $12.53 | $100,904.00 | (< 1%) 2.42M to 2.41M | |
| 16-Apr-24 5:15 PM View: | Liquidia Corp (LQDA) | 12-Apr-24 | Private Sale (Planned) | 8,360 | $14.58 | $121,889.00 | (< 1%) 2.42M to 2.42M | |
| 19-Mar-24 9:46 PM View: | Liquidia Corp (LQDA) | 18-Mar-24 | Private Sale (Planned) | 28,583 | $15.82 | $452,183.00 | (1%) 2.45M to 2.42M | |
| 15-Mar-24 8:05 PM View: | Axsome Therapeutics, Inc. (AXSM) | 15-Mar-24 | Option Exercise | 2,347 | $29.91 | $70,198.80 | 1% 167.67K to 170.01K | |
| 15-Mar-24 8:05 PM View: | Axsome Therapeutics, Inc. (AXSM) | 15-Mar-24 | Planned Option Sale | 2,347 | $71.61 | $168,062.00 | (1%) 170.01K to 167.67K | |
| 15-Mar-24 8:05 PM View: | Axsome Therapeutics, Inc. (AXSM) | 14-Mar-24 | Option Exercise | 29,976 | $24.01 | $719,787.00 | 18% 167.67K to 197.64K | |
| 15-Mar-24 8:05 PM View: | Axsome Therapeutics, Inc. (AXSM) | 14-Mar-24 | Planned Option Sale | 29,976 | $69.70 | $2,089,390.00 | (15%) 197.64K to 167.67K | |
| 16-Jan-24 5:00 PM View: | Liquidia Corp (LQDA) | 11-Jan-24 | Grant | 221,338 | -- | -- | 10% 2.23M to 2.45M | |
| 18-Dec-23 5:02 PM View: | Liquidia Corp (LQDA) | 14-Dec-23 | Market Purchase | 139,665 | $7.16 | $1,000,000.00 | 7% 2.09M to 2.23M | (5%) |
| 13-Jan-23 5:17 PM View: | Liquidia Corp (LQDA) | 11-Jan-23 | Grant | 289,500 | -- | -- | 16% 1.8M to 2.09M | |
| 05-Jan-23 5:35 PM View: | Liquidia Corp (LQDA) | 03-Jan-23 | Option Exercise | 15,807 | -- | -- | < 1% 1.78M to 1.8M | |
| 04-Oct-22 4:25 PM View: | Liquidia Corp (LQDA) | 03-Oct-22 | Option Exercise | 47,423 | -- | -- | 3% 1.75M to 1.8M | |
| 07-Sep-22 8:14 PM View: | Liquidia Corp (LQDA) | 06-Sep-22 | Private Purchase | 43,820 | $5.57 | $243,990.00 | 3% 1.7M to 1.75M | |
| 01-Sep-22 8:36 PM View: | Liquidia Corp (LQDA) | 31-Aug-22 | Private Purchase | 993 | $4.90 | $4,870.17 | < 1% 1.7M to 1.7M | |
| 25-May-22 7:27 PM View: | Liquidia Corp (LQDA) | 24-May-22 | Private Purchase | 28,000 | $3.53 | $98,812.00 | 2% 1.68M to 1.7M | |
| 20-Apr-22 4:35 PM View: | Liquidia Corp (LQDA) | 31-Mar-22 | Grant | 154,167 | -- | -- | 10% 1.51M to 1.66M | |
| 23-Nov-21 7:30 AM View: | Axsome Therapeutics, Inc. (AXSM) | 19-Nov-21 | Market Purchase | 3,950 | $37.30 | $147,350.00 | 2% 163.72K to 167.67K | (1%) |
| 15-Apr-21 9:22 AM View: | Liquidia Corp (LQDA) | 13-Apr-21 | Market Purchase | 99,206 | $2.52 | $249,999.00 | 7% 1.41M to 1.51M | 4% |
| 19-Nov-20 4:11 PM View: | Liquidia Corp (LQDA) | 18-Nov-20 | Acquisition (other) | 1,387,500 | $6.00 | $8,325,000.00 | 7462% 18.6K to 1.41M | |
| 14-Jan-20 4:08 PM View: | Axsome Therapeutics, Inc. (AXSM) | 10-Jan-20 | Option Exercise | 60,186 | $10.46 | $629,756.00 | 58% 103.53K to 163.72K | |
| 12-Nov-19 4:36 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 66,993 | -- | -- | (100%) 66.99K to 0 | |
| 05-Jul-19 7:00 AM View: | Axsome Therapeutics, Inc. (AXSM) | 03-Jul-19 | Option Exercise | 56,620 | $3.04 | $172,178.00 | 121% 46.91K to 103.53K | |
| 02-Jul-19 4:58 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Private Sale (Planned) | 1,308 | $14.17 | $18,534.40 | (2%) 68.3K to 66.99K | |
| 07-Feb-19 4:59 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 05-Feb-19 | Grant | 6,901 | -- | -- | 11% 61.4K to 68.3K | |
| 21-Dec-18 5:12 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 20-Dec-18 | Market Purchase | 1,169 | $6.25 | $7,306.25 | 2% 60.23K to 61.4K | 27% |
| 21-Dec-18 5:12 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 19-Dec-18 | Market Purchase | 28,831 | $6.22 | $179,329.00 | 92% 31.4K to 60.23K | 27% |
| 07-Sep-18 7:18 PM View: | Sangamo Biosciences Inc. (SGMO) | 07-Sep-18 | Market Purchase | 7,408 | $13.56 | $100,487.00 | 296% 2.5K to 9.91K | 31% |
| 12-Jun-18 8:25 PM View: | Sangamo Biosciences Inc. (SGMO) | 11-Jun-18 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 07-Jul-17 6:46 AM View: | Dova Pharmaceuticals Inc. (DOVA) | 05-Jul-17 | Purchase | 31,400 | $17.00 | $533,800.00 | 100% 0 to 31.4K | |
| 30-Mar-17 4:31 PM View: | Axsome Therapeutics, Inc. (AXSM) | 29-Mar-17 | Option Exercise | 42,538 | $4.73 | $201,163.00 | 973% 4.37K to 46.91K | |
| 17-Feb-16 4:10 PM View: | United Therapeutics Corp. (UTHR) | 12-Feb-16 | Disposition | 9,000 | $126.56 | $1,139,040.00 | (25%) 36.09K to 27.09K | (70%) |
| 17-Feb-16 4:10 PM View: | United Therapeutics Corp. (UTHR) | 12-Feb-16 | Option Exercise | 9,000 | $65.80 | $592,200.00 | 33% 27.09K to 36.09K | |
| 28-Jan-16 5:03 PM View: | United Therapeutics Corp. (UTHR) | 27-Jan-16 | Disposition | 3,000 | $125.36 | $376,080.00 | (10%) 30.09K to 27.09K | (72%) |
| 28-Jan-16 5:03 PM View: | United Therapeutics Corp. (UTHR) | 27-Jan-16 | Option Exercise | 3,000 | $65.80 | $197,400.00 | 11% 27.09K to 30.09K | |
| 26-Jan-16 4:12 PM View: | United Therapeutics Corp. (UTHR) | 22-Jan-16 | Disposition | 3,000 | $129.44 | $388,320.00 | (10%) 30.09K to 27.09K | (66%) |
| 26-Jan-16 4:12 PM View: | United Therapeutics Corp. (UTHR) | 22-Jan-16 | Option Exercise | 3,000 | $65.80 | $197,400.00 | 11% 27.09K to 30.09K | |
| 21-Jan-16 4:26 PM View: | United Therapeutics Corp. (UTHR) | 20-Jan-16 | Disposition | 3,000 | $128.61 | $385,830.00 | (10%) 30.09K to 27.09K | (67%) |
| 21-Jan-16 4:26 PM View: | United Therapeutics Corp. (UTHR) | 20-Jan-16 | Option Exercise | 3,000 | $65.80 | $197,400.00 | 11% 27.09K to 30.09K | |
| 20-Jan-16 7:08 AM View: | United Therapeutics Corp. (UTHR) | 15-Jan-16 | Disposition | 3,000 | $133.10 | $399,300.00 | (10%) 30.09K to 27.09K | (62%) |
| 20-Jan-16 7:08 AM View: | United Therapeutics Corp. (UTHR) | 15-Jan-16 | Option Exercise | 3,000 | $65.80 | $197,400.00 | 11% 27.09K to 30.09K | |
| 14-Jan-16 4:51 PM View: | United Therapeutics Corp. (UTHR) | 13-Jan-16 | Disposition | 3,000 | $135.82 | $407,460.00 | (10%) 30.09K to 27.09K | (58%) |
| 14-Jan-16 4:51 PM View: | United Therapeutics Corp. (UTHR) | 13-Jan-16 | Option Exercise | 3,000 | $65.80 | $197,400.00 | 11% 27.09K to 30.09K | |
| 11-Jan-16 4:32 PM View: | United Therapeutics Corp. (UTHR) | 08-Jan-16 | Disposition | 4,000 | $141.50 | $566,000.00 | (13%) 31.09K to 27.09K | (52%) |
| 11-Jan-16 4:32 PM View: | United Therapeutics Corp. (UTHR) | 08-Jan-16 | Option Exercise | 4,000 | $65.80 | $263,200.00 | 15% 27.09K to 31.09K | |
| 07-Jan-16 4:53 PM View: | United Therapeutics Corp. (UTHR) | 06-Jan-16 | Disposition | 4,000 | $147.12 | $588,480.00 | (13%) 31.09K to 27.09K | (46%) |
| 07-Jan-16 4:53 PM View: | United Therapeutics Corp. (UTHR) | 06-Jan-16 | Option Exercise | 4,000 | $65.80 | $263,200.00 | 15% 27.09K to 31.09K | |
| 05-Jan-16 4:44 PM View: | United Therapeutics Corp. (UTHR) | 04-Jan-16 | Disposition | 5,000 | $155.54 | $777,700.00 | (16%) 32.09K to 27.09K | (38%) |
| 05-Jan-16 4:44 PM View: | United Therapeutics Corp. (UTHR) | 04-Jan-16 | Option Exercise | 5,000 | $65.80 | $329,000.00 | 18% 27.09K to 32.09K | |
| 31-Dec-15 12:00 PM View: | United Therapeutics Corp. (UTHR) | 30-Dec-15 | Disposition | 5,000 | $158.53 | $792,650.00 | (16%) 32.09K to 27.09K | (36%) |